Next Generation Sequencing Market, 2022 Dublin,

Dublin, March 27, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Next Generation Sequencing Global market - Forecast to 2022" report to their offering. The global Next Generation Sequencing market is expected to grow at a double digit CAGR to reach $14,722.5 million by 2022.

The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion. But now a human genome can be sequenced at a cost of just $1,000 in one to two days. In the last five years, the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years. The NGS market is classified based on products, technology, end users, application and geography. The global NGS products are further divided into instruments, services and workflow products. The NGS technology is segmented into reversible terminator sequencing, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing (SMRT), and others. The NGS application market is segmented in two different ways, one by sequencing process and the other by field of application. The NGS application market by type of sequencing process has been categorized into genomics, epigenomics, transriptomics, and others. By field of application, the market has been divided into diagnostics, drug discovery and development, biomarker discovery, agriculture and animal research, and others. The NGS market by end users is divided into academic research laboratories, hospitals and clinics, biotech and pharmaceuticals, and other end users, which include nonprofit organizations and commercial labs. Further, the NGS market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. Key Topics Covered: 1. Executive Summary 2. Introduction 2.1 Key Take Aways 2.2 Report Description 2.3 Markets Covered 2.4 Stakeholders 2.5 Research Methodology 2.5.1 Market Size Estimation 2.5.2 Market Crackdown and Data Triangulation 2.5.3 Secondary Sources 2.5.4 Primary Sources 2.5.5 Key Data Points from Secondary Sources 2.5.6 Key Data Points from Primary Sources 2.5.7 Assumptions 3. Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers and Opportunities 3.3.1.1 Reduced Cost and High Speed 3.3.1.2 Increased Usage In Clinical Diagnosis 3.3.1.3 Switch to NGS from Microarray Technology 3.3.1.4 New & Emerging Applications of NGS Technology 3.3.1.5 Growth of Personalized Medicine 3.3.1.6 Increased Medical Spending 3.3.2 Restraints and Threats 3.3.2.1 Complications In NGS Data Storage 3.3.2.2 Standardization of NGS For Diagnostic Application 3.3.2.3 Grants and Funding For NGS Infrastructure 3.3.2.4 Lack of Skilled Labor 3.3.2.5 Huge and Complex NGS Data Interpretation 3.3.2.6 Ethical and Legal Issues to NGS 3.4 Technological Advancements 3.4.1 Nanopore Sequencing Based Techniques 3.4.1.1 Electronic Biosciences Nanopore Sequencing 3.4.1.2 Roche's Nanotag Chemistry 3.4.1.3 Nabsys Nanopore Sequencer 3.4.1.4 Stratos Nanopore Sequencing 3.4.2 Electronic Optica'S Mad-Leem 3.4.3 Genapsys Genius 3.4.4 Lasergen'S Lightening Terminator Chemistry 3.4.5 Quantumdx Handheld Sequencing Instrument 3.4.6 Zs Genetics Adf-Stem 3.5 Regulatory Affairs 3.6 Porter'S Five Force Analysis 3.7 Patent Trends 3.8 Market Share Analysis by Major Players 4. Next Generation Sequencing Global Market, by Technology 4.1 Introduction 4.2 Reversible Terminator Sequencing 4.3 Ion Semicoductor Sequencing 4.4 Sequencing by Ligation 4.5 Single Molecule Real-Time Sequencing (SMRT) 4.6 Others 5. NGS Global Market, by Product Type 5.1 Introduction 5.1.1 Instruments 5.1.2 Services 5.1.2.1 Data Analysis Services 5.1.2.2 Sequencing Services 5.1.3 Workflow Products 6. Next-Generation Sequencing Global Market, by Application 6.1 Introduction 6.2 NGS Global Application Market, by Process 6.2.1 Genomics 6.2.1.1 Whole Genome Sequencing 6.2.1.2 Exome Sequencing 6.2.1.3 Target Resequencing 6.2.1.4 De Novo Sequencing 6.2.2 Epigenomics 6.2.2.1 Chip Sequencing 6.2.2.2 Methyl Sequencing 6.2.3 Transcriptomics 6.2.3.1 Rna Sequencing 6.2.4 Others 6.3 NGS Global Application Market, by Field Type 6.3.1 Diagnostics 6.3.1.1 Cancer Diagnostics 6.3.1.2 Infectious Disease Diagnostics 6.3.1.3 Genetic Screening 6.3.1.4 Transplantation Diagnostics 6.3.2 Drug Discovery and Development 6.3.3 Biomarker Discovery 6.3.4 Agriculture and Animal Research 6.3.5 Other Applications 7. Next-Generation Sequencing Global Market, by End Users 7.1 Introduction 7.2 Academic Research 7.3 Hospitals and Clinics 7.4 Biotech/Pharmaceuticals 7.5 Other End Users 8. Next-Generation Sequencing Global Market, by Region 9. Company Developments 9.1 Introduction 9.1.1 New Product Launch As A Major Growth Strategy of NGS Market Players 9.2 New Product Launch 9.3 Agreements, Partnerships & Collaborations 9.4 Acquisitions 9.5 Other Developments 10. Major Player Profiles 10.1 Agilent Technologies, Inc. 10.2 BGI (Beijing Genomics Institute) 10.3 Dnastar, Inc. 10.4 Eurofin Genomics 10.5 Illumina, Inc. 10.6 Oxford Nanopore Technologies Ltd 10.7 Pacific Biosciences of California, Inc. 10.8 Qiagen N.V. 10.9 Roche HoldiNGS Ag 10.10 Thermo Fisher Scientific, Inc. Companies Mentioned - 10X Genomics - Adaptive Biotechnologies Corporation - Agilent Technologies - Amoy Diagnostics CO - Archerdx - Asuragen - BGI - Biomatters LTD - Biomerieux - Cancer Genetics, INC. - Caredx, INC. - Danaher Corporation - Direct Genomics - DNA Electronics - Dnastar, INC. - Dnavision Sa - Electron Optica - Electronic Biosciences - Eurofins Scientific - Flowjo Llc - Genapsys,INC. - Genewiz - Genomatix Software Gmbh - Igenomix - Illumina, INC. - Invicta - Macrogen - Nabsys - Noblegen - Novogene - Oxford Nanopore Technologies - Pacific Biosciences - Qiagen N.V. - Quantumdx - Real Time Genomics - Roche Holdings - Seqomics - Seracare Life Sciences - Strand Lifesciences Pvt LTD - Stratos Genomics - Thermo Fisher Scientific, INC. - Toma Biosciences - Two Pore Guys, INC. - Vela Diagnostics - Veritas Genetics - Wafergen Biosystems - ZS Genetics For more information about this report visit http://www.researchandmarkets.com/research/3c...generation

About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Molecular Diagnostics